Inhibitory leukocyte immunoglobulin-like receptors: Immune checkpoint proteins and tumor sustaining factors

Written By Lara Wilson

Kang X. et al. 2016. Cell Cycle. 15(1):25-40.

Lara Wilson
Previous

A Novel Anti-LILRB4 CAR-T Cell for the Treatment of Monocytic AML
Next

The ITIM-containing receptor LAIR1 is essential for acute myeloid leukaemia development